Finance Watch: Two New VC Funds Raise $500m; One New US IPO; And Galena's 'Strategic Review'

Pivotal and Biomatics launch new VC funds totaling $300m and $200m, respectively; Spero raises a $51.7m Series C round; BeyondSpring is March's only US IPO, so far; Aurinia and TG Therapeutics capitalize on positive data with secondary offerings; and Galena hires a "strategic review" advisor.

trading

Two new life science venture capital funds launched recently with $500m to invest in biopharmaceutical and genomics firms, showing that funding for early-stage companies continues to be an attractive investment space, despite the slowdown in initial public offerings – one of two major exits for VC investors.

The new venture capital firm Pivotal bioVenture Partners in San Francisco has launched with $300m from a single limited partner...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip